Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Regulatory and Compliance Updates news
13 November 2025
EnviTec Biogas and TT-Line Partner for Bio-LNG Supply
TT-Line's Peter Pan successfully bunkers 40 tons of bio-LNG, advancing sustainable maritime transport under EU regulations for reduced greenhouse gas emissions.
11 November 2025
Ercros Reports EUR 4M EBITDA, EUR 41M Losses
Weak demand, high energy costs, and competition impact results. Cost reduction plan on track. Solid liquidity. Awaiting EU support. Bondalti takeover bid approved with conditions.
11 November 2025
BASF and Beyond Suncare Applaud WHO's Inclusion of Sunscreen as Essential Medicine
WHO lists broad-spectrum sunscreen as essential, boosting access and affordability, especially for vulnerable groups like those with albinism.
10 November 2025
Rompetrol Rafinare's Ecological Rehabilitation of Vega Refinery Lagoons
The project neutralizes emissions, protects water, and restores ecosystems, using efficient treatment to transform acidic tars into inert waste, ensuring compliance with environmental standards.
10 November 2025
Boehringer Ingelheim's Zongertinib Receives FDA Priority Voucher for HER2-Mutant NSCLC
Zongertinib gains FDA's Priority Voucher, expediting review for HER2-mutant NSCLC treatment. A supplemental New Drug Application is planned for first-line use.
10 November 2025
Novo Nordisk: Wegovy® Shows Liver Health Benefits Beyond Weight Loss in MASH Patients
Semaglutide 2.4 mg improves liver health in MASH patients, showing benefits across weight loss levels and diverse demographics, according to ESSENCE trial data.
News type
New Projects and Expansions
New Projects and Expansions
Project Updates and Milestones
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Innovation and Product Development
Operational Changes and Investments
Operational Changes and Investments
Sustainability and Environmental Initiatives
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Financial Performance and Strategy
Executive Appointments and Governance Changes
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Analytics
Learn more
10 November 2025
Roche's Fenebrutinib Shows Promising Phase III Results for Multiple Sclerosis
Fenebrutinib reduces relapses in RMS and slows disability in PPMS, showing potential as a high-efficacy oral treatment. Full data expected by 2026 for regulatory submission.
9 November 2025
Merck's Enlicitide Decanoate Cuts LDL-C in HeFH Patients in Phase 3 Trial
Enlicitide decanoate shows significant LDL-C reduction in HeFH patients, with a safety profile similar to placebo, in the CORALreef HeFH trial.
7 November 2025
Novamont's Mater-Bi Mulch Film Certified as EU Inorganic Soil Improver
Mater-Bi mulch film is biodegradable, doesn't release microplastics, and meets EU standards, aiding soil health and reducing agricultural plastic waste.
6 November 2025
Johnson & Johnson's DARZALEX FASPRO®: First FDA-Approved Treatment for High-Risk Smoldering Multiple Myeloma
DARZALEX FASPRO® reduces progression risk to active multiple myeloma by 51% in high-risk patients, marking a shift in treatment strategy.
6 November 2025
Novo Nordisk's CagriSema Reduces Blood Pressure and Inflammation, Lowers Heart Disease Risk
CagriSema shows potential in reducing blood pressure, inflammation, and heart disease risk, with ongoing trials to assess cardiovascular outcomes.
6 November 2025
Novo Nordisk and U.S. Administration to Lower GLP-1 Costs and Expand Access
Novo Nordisk to lower semaglutide prices in 2026, expand Medicare Part D coverage, and expects a slight negative impact on global sales growth.
6 November 2025
Lilly and U.S. Government Expand Access to Obesity Drugs
Medicare beneficiaries to access obesity drugs at $50/month. LillyDirect offers self-pay options. FDA approval pending.
6 November 2025
Johnson & Johnson's CAPLYTA® Approved by FDA for Major Depressive Disorder Treatment
FDA approves CAPLYTA® as adjunctive therapy for major depressive disorder, showing significant symptom improvement and safety in trials, with potential for remission.
6 November 2025
Clariant and FUHUA Form Joint Venture for Flame Retardants
The venture will produce halogen-free flame retardants in China, addressing regulatory needs. Clariant expands capacity with a CHF 100M investment and a new production line in Cangzhou.
6 November 2025
Sasol Develops Methane Rich Gas Solution for South Africa's Post-2028 Gas Supply
Sasol plans to supply Methane Rich Gas from 2028-2030 to bridge the gas supply gap, pending regulatory approval, while transitioning to LNG for long-term needs.
5 November 2025
Hyundai Transys and BASF Develop Modular Seat with Elastollan TPU
The new seat uses Elastollan TPU with SCF foaming for customizable, sustainable automotive interiors, offering recyclability, reduced VOCs, and energy efficiency.
5 November 2025
Novo Nordisk's Wegovy® Helps Users Meet Health Targets, Reducing Obesity Risks
Wegovy® users achieved BMI and waist targets, improving cardiovascular health and reducing obesity-related risks, as shown in the STEP UP trial.
5 November 2025
EU Boosts Climate Goals Before COP30
The EU commits to reducing GHG emissions by 66.25-72.5% by 2035 and 90% by 2040, aiming for climate neutrality by 2050, ahead of COP30.
5 November 2025
Novo Nordisk Unveils New Oral Semaglutide Analyses at ObesityWeek 2025
Oral semaglutide 25 mg shows improved blood sugar control, cardiovascular risk factors, and weight loss efficacy, comparable to injectable form, across various patient groups.
4 November 2025
BASF Introduces Cavipor Clay Foam for Insulation Market
Cavipor clay foam, now approved for floors and roofs, enhances energy efficiency and sustainability in building insulation, with easy application and recyclability.
4 November 2025
Asahi Kasei's Nefecon Added to KDIGO Guidelines for IgA Nephropathy Treatment
Nefecon's inclusion in KDIGO 2025 guidelines highlights its role in IgAN treatment, supporting Asahi Kasei's strategic growth in healthcare.
3 November 2025
Clariant Wins Petrobras Best Suppliers Award for Chemicals
Clariant excels in quality, ESHA, delivery, and contract management, scoring 5.7/6 on Petrobras's Supplier Performance Index, enhancing its reliability and performance.
3 November 2025
Takeda's Dengue Vaccine Proven Effective for 7 Years
QDENGA shows long-term safety and efficacy, reducing dengue cases and hospitalizations. Approved in 41 countries, it remains effective across all virus serotypes with no new safety issues.
3 November 2025
Uniper Sells Uniper Wärme GmbH to Steag Iqony Group
The sale fulfills EU conditions for Uniper's stabilization package. Uniper Wärme serves 14,400 customers with a 750 km district heating network using CHP and eco-friendly heat sources.
3 November 2025
Roche's Gazyva Shows Significant Disease Reduction in Lupus Study
Phase III study shows Gazyva meets primary and secondary endpoints in SLE, potentially setting a new care standard by targeting B cells and reducing organ damage risk.
31 October 2025
Johnson & Johnson Seeks FDA Approval for STELARA in Pediatric Ulcerative Colitis
sBLA submitted for STELARA to treat pediatric ulcerative colitis, backed by Phase 3 UNIFI Jr trial data, aiming to expand treatment options for children.
31 October 2025
Iberdrola Acquires PREVI's 30.29% Stake in Neoenergia
Iberdrola now controls 84% of Neoenergia, investing €1.92 billion. Neoenergia leads Brazil's distribution with 40M customers and 3,800 MW renewable capacity.
30 October 2025
LANXESS Launches Sustainable Additive for Extreme Pressure
Additin RC 2515 now uses over 80% sustainable materials, reducing PCF by 34%. It excels in extreme pressure applications and is ISCC PLUS-certified.
30 October 2025
EIB Provides €90 Million for TVO's Olkiluoto Nuclear Plant Upgrades
The EIB funds upgrades to enhance safety and reliability of Olkiluoto's nuclear units, supporting Finland's energy independence and EU climate goals.
Next →
